Susceptibility of Naegleria fowleri to delta 9-tetrahydrocannabinol.

Antimicrobial Agents and Chemotherapy
H L PringleL S Harris

Abstract

Growth of the pathogenic amoeboflagellate Naegleria fowleri is inhibited by delta 9-tetrahydrocannabinol (delta 9-THC). delta 9-THC is amoebostatic at 5 to 50 micrograms/ml. delta 9-THC prevents enflagellation and encystment, but does not impair amoeboid movement. Calf serum at 10 and 20% (vol/vol) reduces the antiamoeba activity of delta 9-THC. Only 1-methoxy delta 8-tetrahydrocannabinol, of 17 cannabinoids tested, failed to inhibit growth of N. fowleri. Antinaeglerial activity was not markedly altered by opening the pyran ring, by converting the cyclohexyl ring to an aromatic ring, or by reversing the hydroxyl and pentyl groups on the benzene ring. delta 9-THC prevented the cytopathic effect of N. fowleri on African green monkey (Vero) cells and human epithelioma (HEp-2) cells in culture. delta 9-THC afforded modest protection to mice infected with N. fowleri.

References

Jan 1, 1978·Journal of Clinical Pathology·R T Cursons, T J Brown
Mar 1, 1976·Journal of the National Cancer Institute·A C WhiteR A Carchman
Sep 1, 1975·Journal of the National Cancer Institute·A E MunsonR A Carchman
May 1, 1976·Infection and Immunity·A C AdamsS G Bradley
Mar 7, 1970·British Medical Journal·J ApleyD C Warhurst
Nov 1, 1968·American Journal of Clinical Pathology·C G ButtR W Knorr
Apr 28, 1962·JAMA : the Journal of the American Medical Association·V T ANDRIOLE, H M KRAVETZ

❮ Previous
Next ❯

Citations

Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·S K Tahir, A M Zimmerman
May 17, 2002·Progress in Neurobiology·Emmanuel S OnaiviGeorge R Uhl
May 19, 2010·Antimicrobial Agents and Chemotherapy·Rafik DeyJacques Bodennec
Oct 30, 2016·Acta Tropica·Ruqaiyyah SiddiquiNaveed Ahmed Khan
Jul 1, 1981·Journal of Bacteriology·M PattersonS G Bradley
Mar 1, 1988·Microbiological Reviews·F Marciano-Cabral
Jan 3, 2018·Organic Letters·Zachary P ShultzJames W Leahy

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.